| EPE0776 | Performance of oral versus blood-based HIVST cascade in Nigeria: unitaid-funded STAR programmatic experience | E-poster | Implementation science and scale up of HIV testing |
| MOPEB10 | Performance of rifampicin resistant TB regimens used as standard-care in the TB-PRACTECAL clinical trial | Poster exhibition | Co-infections (including opportunistic infections) |
| OAB0102 | Persistent accelerated epigenetic aging is associated with altered neuroimaging and immune biomarkers in a longitudinal cohort of vertically-acquired HIV-positive adolescents | Oral abstract session with live Q&A | Antiretroviral therapies and clinical issues in infants, children and adolescents |
| EPA0102 | Persistent immune alterations in individuals with Long-COVID during a 6-months period | E-poster | SARS-CoV-2 virology, pathogenesis, and host immune responses, vaccines and immunotherapies |
| EPD0571 | Perspectives of people living with HIV on ART-related weight change and healthy weight | E-poster | Social and behavioural aspects and approaches to HIV |
| EPD0534 | Perspectives of the community in HIV research for U=U and digital advocacy | E-poster | Social science theories, concepts and methods |
| OAA0403 | Perturbation of mucosal granulocytic effector cells in lentivirus infections | Oral abstract session with live Q&A | Host immune responses, vaccines and immunotherapies |
| EPE0802 | Pharmacist perspectives on the implementation of pharmacist-initiated PrEP in California | E-poster | Implementation science and scale up of prevention |
| TUPEB07 | Pharmacokinetic bridging with oral Lenacapavir for missed subcutaneous Q6M dosing | Poster exhibition | Antiretroviral therapies and clinical issues in adults |
| EPC0394 | Pharmacokinetics and safety of long-acting islatravir and its novel prodrug islatravir alafenamide implants for HIV prevention | E-poster | HIV prevention research |